MX2016000107A - Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. - Google Patents
Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.Info
- Publication number
- MX2016000107A MX2016000107A MX2016000107A MX2016000107A MX2016000107A MX 2016000107 A MX2016000107 A MX 2016000107A MX 2016000107 A MX2016000107 A MX 2016000107A MX 2016000107 A MX2016000107 A MX 2016000107A MX 2016000107 A MX2016000107 A MX 2016000107A
- Authority
- MX
- Mexico
- Prior art keywords
- mammalian milk
- mammal
- infectious disease
- milk osteopontin
- active
- Prior art date
Links
- 102000004264 Osteopontin Human genes 0.000 title abstract 4
- 108010081689 Osteopontin Proteins 0.000 title abstract 4
- 239000008267 milk Substances 0.000 title abstract 4
- 210000004080 milk Anatomy 0.000 title abstract 4
- 235000013336 milk Nutrition 0.000 title abstract 4
- 230000002708 enhancing effect Effects 0.000 title abstract 3
- 230000004043 responsiveness Effects 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 5
- 208000035473 Communicable disease Diseases 0.000 abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Marine Sciences & Fisheries (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La invención divulgada proporciona osteopontina láctea de mamífero y/o truncamiento activo o péptido activo de la misma para mejorar la respuesta inmunitaria a una enfermedad infecciosa en un mamífero, por ejemplo un sujeto humano, así como mejorar la eficacia de vacunación para el tratamiento profiláctico o terapéutico de una enfermedad infecciosa en mamíferos, tales como humanos. La invención comprende además un sistema de vacunas, para utilizar en el tratamiento profiláctico o terapéutico de una enfermedad infecciosa en un mamífero, que comprende una vacuna y una osteopontina láctea de mamífero y/o un truncamiento activo o péptido activo de la misma para administración oral a un mamífero, así como métodos de mejora de la resistencia inmune a una enfermedad infecciosa en un mamífero por administración de una vacuna y una osteopontina láctea de mamífero y/o un truncamiento activo de la misma.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843185P | 2013-07-05 | 2013-07-05 | |
| EP13175267 | 2013-07-05 | ||
| PCT/EP2014/064339 WO2015001092A1 (en) | 2013-07-05 | 2014-07-04 | Mammalian milk osteopontin for enhancing immune responsiveness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016000107A true MX2016000107A (es) | 2016-06-07 |
| MX369925B MX369925B (es) | 2019-11-25 |
Family
ID=48740972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000107A MX369925B (es) | 2013-07-05 | 2014-07-04 | Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9956283B2 (es) |
| EP (1) | EP3016673B1 (es) |
| JP (1) | JP6509833B2 (es) |
| KR (1) | KR102307002B1 (es) |
| CN (1) | CN105407910B (es) |
| AU (1) | AU2014286123B2 (es) |
| BR (1) | BR112016000067B1 (es) |
| CA (1) | CA2916821C (es) |
| CL (1) | CL2015003803A1 (es) |
| DK (1) | DK3016673T3 (es) |
| EA (1) | EA034654B1 (es) |
| ES (1) | ES2656474T3 (es) |
| MX (1) | MX369925B (es) |
| NZ (1) | NZ715430A (es) |
| PH (1) | PH12015502844A1 (es) |
| PL (1) | PL3016673T3 (es) |
| PT (1) | PT3016673T (es) |
| WO (1) | WO2015001092A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112040973B (zh) * | 2018-04-25 | 2022-03-29 | 合生元（广州）健康产品有限公司 | 用作药物的骨桥蛋白和2’-岩藻糖基乳糖的组合 |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
| CN113424962A (zh) * | 2020-09-21 | 2021-09-24 | 黑龙江飞鹤乳业有限公司 | 提高免疫力的营养组分、含有其的食品或保健品及其用途 |
| CN113475720B (zh) * | 2021-06-15 | 2023-07-25 | 合生元（广州）健康产品有限公司 | 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用 |
| WO2023144416A1 (en) | 2022-01-31 | 2023-08-03 | Société des Produits Nestlé S.A. | Compositions comprising osteopontin (opn) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998056405A1 (en) * | 1997-06-10 | 1998-12-17 | Whitehead Institute For Biomedical Research | A method of modulating immune response with osteopontin |
| EP0989859B1 (en) * | 1997-06-11 | 2003-08-13 | Acorda Therapeutics | Cns neuroregenerative compositions and methods of use |
| AU773350B2 (en) * | 1999-04-15 | 2004-05-20 | Children's Medical Center Corporation | Methods and compositions for modulating an immune response |
| DE60119077T2 (de) | 2000-01-07 | 2006-09-07 | Arla Foods Amba | Verfahren zur isolierung von osteopontin aus milch |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| WO2003100007A2 (en) * | 2002-05-24 | 2003-12-04 | Schering-Plough Ltd. | Eta-1 gene and methods for use |
| NZ546398A (en) | 2003-09-18 | 2009-03-31 | Arla Foods Amba | Infant formula |
| KR20130009866A (ko) * | 2003-09-18 | 2013-01-23 | 아를라 푸즈 에이엠비에이 | 유아용 조제유 |
| KR20090123115A (ko) * | 2008-05-27 | 2009-12-02 | 한국생명공학연구원 | 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법 |
| JP5967665B2 (ja) * | 2011-03-03 | 2016-08-10 | アーラ フーズ エーエムビーエーＡｒｌａ Ｆｏｏｄｓ ａｍｂａ | Ｃｍｐまたはカゼイン種を含有する供給物を使用してオステオポンチンを単離する方法 |
| EA201491010A1 (ru) * | 2011-12-07 | 2015-01-30 | Арла Фудз Амба | Варианты остеопонтина для применения в подавлении или предупреждении опухолевого роста и композиции, содержащие такие варианты остеопонтина |
-
2014
- 2014-07-04 AU AU2014286123A patent/AU2014286123B2/en active Active
- 2014-07-04 NZ NZ715430A patent/NZ715430A/en unknown
- 2014-07-04 PL PL14735964T patent/PL3016673T3/pl unknown
- 2014-07-04 DK DK14735964.0T patent/DK3016673T3/da active
- 2014-07-04 US US14/903,049 patent/US9956283B2/en active Active
- 2014-07-04 ES ES14735964.0T patent/ES2656474T3/es active Active
- 2014-07-04 JP JP2016522645A patent/JP6509833B2/ja active Active
- 2014-07-04 EP EP14735964.0A patent/EP3016673B1/en active Active
- 2014-07-04 KR KR1020167002892A patent/KR102307002B1/ko active IP Right Grant
- 2014-07-04 PT PT147359640T patent/PT3016673T/pt unknown
- 2014-07-04 BR BR112016000067-6A patent/BR112016000067B1/pt active IP Right Grant
- 2014-07-04 EA EA201690057A patent/EA034654B1/ru not_active IP Right Cessation
- 2014-07-04 CA CA2916821A patent/CA2916821C/en active Active
- 2014-07-04 WO PCT/EP2014/064339 patent/WO2015001092A1/en active Application Filing
- 2014-07-04 CN CN201480038124.7A patent/CN105407910B/zh active Active
- 2014-07-04 MX MX2016000107A patent/MX369925B/es active IP Right Grant
-
2015
- 2015-12-21 PH PH12015502844A patent/PH12015502844A1/en unknown
- 2015-12-31 CL CL2015003803A patent/CL2015003803A1/es unknown
-
2018
- 2018-04-04 US US15/945,517 patent/US10772955B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX369925B (es) | 2019-11-25 |
| US20180289798A1 (en) | 2018-10-11 |
| EA201690057A1 (ru) | 2016-07-29 |
| US10772955B2 (en) | 2020-09-15 |
| EP3016673A1 (en) | 2016-05-11 |
| CL2015003803A1 (es) | 2016-08-05 |
| PT3016673T (pt) | 2018-01-30 |
| PH12015502844B1 (en) | 2016-03-28 |
| EP3016673B1 (en) | 2017-10-25 |
| AU2014286123B2 (en) | 2019-02-28 |
| PL3016673T3 (pl) | 2018-04-30 |
| DK3016673T3 (da) | 2018-01-29 |
| WO2015001092A1 (en) | 2015-01-08 |
| US20160136268A1 (en) | 2016-05-19 |
| KR102307002B1 (ko) | 2021-10-05 |
| BR112016000067B1 (pt) | 2022-08-30 |
| CA2916821A1 (en) | 2015-01-08 |
| EA034654B1 (ru) | 2020-03-03 |
| US9956283B2 (en) | 2018-05-01 |
| CN105407910B (zh) | 2019-12-03 |
| AU2014286123A1 (en) | 2016-01-21 |
| CN105407910A (zh) | 2016-03-16 |
| BR112016000067A2 (es) | 2017-09-05 |
| ES2656474T3 (es) | 2018-02-27 |
| JP2016529217A (ja) | 2016-09-23 |
| PH12015502844A1 (en) | 2016-03-28 |
| CA2916821C (en) | 2023-10-03 |
| KR20160030960A (ko) | 2016-03-21 |
| JP6509833B2 (ja) | 2019-05-08 |
| NZ715430A (en) | 2022-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201800052A (es) | Anticuerpos que neutraliza el virus respiratorio sincitial humano | |
| MX2017009308A (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| PH12015502844A1 (en) | Mammalian milk osteopontin for enhancing immune responsiveness | |
| WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| PT2643345T (pt) | Péptidos imunogénicos para utilizar na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunitárias a alofatores, doenças alérgicas, tumores, rejeição de enxertos e respostas imunitárias contra vetores virais usados para a terapêutica de genes ou na vacinação genética | |
| MX2013004817A (es) | Enfermedad inflamatoria. | |
| EP4272750A3 (en) | Protein antigens that provide protection against pneumococcal colonization and/or disease | |
| WO2013106834A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| EA202090699A3 (ru) | Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения | |
| MX345704B (es) | Vacuna bovinas y métodos. | |
| EA201891124A3 (ru) | Новые мукозные адъюванты и системы доставки | |
| CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
| PH12015501716A1 (en) | Anti-mycoplasma spp. subunit vaccine | |
| MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| WO2015054678A3 (en) | Human papilloma virus therapeutic vaccine | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| BR112014020025A2 (pt) | vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas | |
| NZ704188A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
| MX2014008853A (es) | Inulina y formulaciones de acetato de inulina. | |
| GB2515222A (en) | Use of flagellin as a vaccine | |
| MX363044B (es) | Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos. | |
| WO2011084967A3 (en) | Methods and compositions for providing protective immunity in the elderly | |
| WO2013173256A3 (en) | New and improved influenza vaccines | |
| RU2015118636A (ru) | Тени бактерий L. casei 583 для стимулирования врожденного иммунного ответа и их применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |